Technical Analysis for OBMP - Oncbiomune Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 0.28 -44.00% -0.2200
OBMP closed down 44.0 percent on Friday, October 18, 2019, on 2 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical OBMP trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
180 Bullish Setup Bullish Swing Setup -44.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -44.00%
Wide Bands Range Expansion -44.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -37.78%
Wide Bands Range Expansion -37.78%
Down 3 Days in a Row Weakness -37.78%
180 Bullish Setup Bullish Swing Setup -53.33%
Upper Bollinger Band Walk Strength -53.33%

Older signals for OBMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
OncBioMune Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in various cancer therapies. The Company focuses on developing breast and prostate cancer therapeutic vaccines, and a process for the growth of cancer cells and targeted chemotherapies. Its product portfolio consists of approximately three target therapies and a vaccine platform. The Company's lead product, ProscaVax is indicated for prostate cancer. Its focuses on planning Phase II clinical trials of ProscaVax. The Company is also focused on development of its other technologies, such as the paclitaxel-albumin conjugate. It also has a portfolio of targeted therapies, some of which are biosimilars to drugs, including paclitaxel (Abraxane). The Company is focused on the tumor specific immune status of patients both pre and post immunotherapy that uses autologous tumor antigens to immunize patients. The Company focuses on offering Bekunis for constipation and Cirkused for stress.
Medicine Biotechnology RTT Cancer Organic Compounds Chemotherapy Immunotherapy Oncology Prostate Cancer Tumor Antineoplastic Drugs Constipation Targeted Therapy Benzamides Cancer Therapies Benzoates Breast And Prostate Cancer Chemotherapies Paclitaxel
Is OBMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.05
52 Week Low 0.0021
Average Volume 2,373,108
200-Day Moving Average 0.0249
50-Day Moving Average 0.0725
20-Day Moving Average 0.1753
10-Day Moving Average 0.3477
Average True Range 0.1182
ADX 19.53
+DI 43.8166
-DI 36.5916
Chandelier Exit (Long, 3 ATRs ) 0.6954
Chandelier Exit (Short, 3 ATRs ) 0.3567
Upper Bollinger Band 0.7585
Lower Bollinger Band -0.4079
Percent B (%b) 0.59
BandWidth 665.373645
MACD Line 0.1256
MACD Signal Line 0.093
MACD Histogram 0.0327
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.6100
Resistance 3 (R3) 0.6400 0.5600 0.5550
Resistance 2 (R2) 0.5600 0.4760 0.5450 0.5367
Resistance 1 (R1) 0.4200 0.4240 0.3800 0.3900 0.5183
Pivot Point 0.3400 0.3400 0.3200 0.3250 0.3400
Support 1 (S1) 0.2000 0.2560 0.1600 0.1700 0.0417
Support 2 (S2) 0.1200 0.2040 0.1050 0.0233
Support 3 (S3) -0.0200 0.1200 0.0050
Support 4 (S4) -0.0500